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Direct Method
Drug susceptibility testing can be performed
based on mycobacterial cultivation on solid media,
either egg or agar-based.  In the direct test a set of
drug-containing and drug-free media is inoculated
directly with concentrated specimen.  The advantage
of the direct method over indirect method is that the
results are available sooner (within 3 weeks on agar
plates), and better represent the patient’s original
bacterial population
Indirect  Method
In the indirect test, the pure culture is
inoculated in drug containing and drug-free slopes
either in egg-based Lowenstein-Jensen medium or
agar based 7H11 medium.
PHENOTYPIC METHODS
Absolute concentration method
This method uses a standardized inoculum
grown on drug free media and media containing
graded concentrations of the drug(s) to be tested.
Several concentrations of each drug are tested, and
resistance is expressed in terms of the lowest
concentration of the drug that inhibits growth; i.e.
minimal inhibitory concentration (MIC).  This
method is greatly affected by the viability of the
organism.
Resistance ratio method
This would compares the growth of
unknown strains of tubercle bacilli with that of
standard laboratory strain (H37Rv).  Parallel sets of
media containing two-fold dilutions of the drug are
inoculated with standard strains of tubercle bacilli.
Resistance is expressed as the ratio of the MIC of
the test strain to the MIC of the standard strain in
the same set.  This test is also greatly affected by
the inoculum size as well as the viability of the strains.
In addition, any variation in the susceptibility of the
standard strain also affects the RR of the test strain.
Proportion method
This method enables a precise estimation
of the proportion of mutants resistant to a given drug.
Several 10-fold dilutions of inoculum are planted on
to both control (drug-free) and drug-containing
media; at least one dilution should yield isolated
countable (50-100) colonies.  When these numbers
are adjusted by multiplying by the dilution of the
inoculum used, the total number of viable colonies
on the control medium, and the number of mutant
colonies resistant to the drug concentrations tested
may be estimated.  The proportion of bacilli resistant
to a given drug is then determined by expressing the
resistant portion as a percentage of the total
population used.  The proportion method is currently
the method of choice for estimating drug resistance
and this principle is being applied to the following
rapid testing methods:
(i) BACTEC 460 (First and second
line);
(ii) MGIT 960;
(iii) MB/BacT system; and
(iv) ESP II system
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RECENTLY DEVELOPED PHENOTYPIC
METHODS
E-test (Commercially available as AB BIODISK)
The E-test is based on determination of drug
susceptibility using strips containing gradients of
impregnated antibiotics.  There are reports about a
high rate of false resistance by this method when
compared with BACTEC or conventional LJ
proportion methods1.
Microwell Alamar blue assay and microplate
tetrazolium reduction assay
These tests are colorimetric based on the
oxidation-reduction of the dye Alamar blue or MTT
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide).  Drug resistance is detected by the
reduction of the dye from blue to pink due to the
oxidation-reduction metabolism of viable
organisms2,3.
Mycolic acid index susceptibility testing
This is a modification of the original mycolic
acid analysis by HPLC where a coumarin compound is
used as a fluorescent derivatizing agent of mycolic acid
instead of p-bromophenacyl bromide.  The drug sensitivity
is assessed by measuring the total area under mycolic acid
(TAMA) chromatographic peaks of a culture of
M.tuberculosis, and this area has a very good correlation
with log CFU per milliliter.  Depending on the signal and
quantification of this procedure, drug susceptibility pattern
can be carried out as a rapid method4.
Microscopic observation of broth cultures - Drug
susceptibility assay
This novel method of microscopic observation
of broth culture with drugs is used for drug sensitivity
testing.  It is a relatively inexpensive and fairly rapid drug
susceptibility testing method with a high sensitivity and
specificity and is suited for disease endemic developing
countries5.
Micro-colony detection
This employs observation of micro-colonies
of M.tuberculosis with the help of a microscope, on
a thin layer of 7H11 agar plate and is used for drug
sensitivity testing.  It is less expensive than the
conventional proportion method, and may be a good
low-cost alternative for resource poor countries6.
Pha B assay
This is a new phenotypic culture drug
susceptibility testing method named as phage
amplified biologically (pha B), and is based on the
ability of viable M.tuberculosis to support the
replication of an infecting mycobacteriophage; non-
infecting exogenous phages are inactivated by
chemical treatment.  The number of endogenous
phages, which is an indication of the original number
of viable M.tuberculosis, is determined after cycles
of infection, replication and release in rapidly growing
mycobacteria.    In the case of drug-resistant
M.tuberculosis, bacilli will remain viable and protect
the mycobacteriophage.  Any mycobacteriophage
protected within viable bacilli replicate and ultimately
lyse their host.  For rapid detection, the released
mycobacteriophages are mixed with rapidly growing
M.smegmatis host in which they undergo rapid cycle
of infection, replication and lysis.  Lysis is easily
seen as clear areas or plaques in a lawn culture of
M.smegmatis.  The number of plaques generated
from a given sample is directly proportional to the
number of protected mycobacteriophages, which is
dependent on the number of tubercle bacilli that
remain viable after drug treatment (i.e. drug-
resistant).  Gingeras et al7 reported successful
application of this assay.
Luciferase reporter phage assay
In this technique, viable mycobacteria are
infected with reporter phages expressing firefly
luciferase gene.  Easily detectable signals are seen a
few minutes after the infection of M.tuberculosis with
reporter phages.  Light production requires
metabolically active M.tuberculosis cells in which
reporter phages replicate and luciferase gene is
expressed.  When drug-susceptible M.tuberculosis
strains are incubated with specific anti-tuberculosis
drugs, they fail to produce light after infection with
luciferase reporter phages.  In contrast, drug resistant
strains are unaffected by the drugs and produce light
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at levels equivalent to those documented for untreated
controls after infection with reporter phages8.  The
other reporter molecule described is the green
fluorescence protein (GPF) of the jellyfish Aequorea
Victoria.  This reporter system does not require co-
factors or substances due to intrinsic fluorescence
nature of the GPF9.  These tests have generally good
sensitivity and reproducibility but are yet to be used
in routine clinical laboratories.
GENOTYPIC METHODS
These are essentially required for the rapid
identification of multi drug resistant (MDR) TB
strains.  In contrast to other bacteria, drug resistance
in M.tuberculosis is not plasmid mediated.  Most of
the molecular events relating to the chromosomal
basis of drug resistance have been elucidated.  The
phrase “MDR state” in mycobacteriology refers to
simultaneous resistance to at least Rifampicin and
INH (with or without resistance to other drugs).
Genetic and molecular analysis of drug resistance in
MDR TB suggests that the bacilli usually acquire
resistance either by alteration of the drug target by
mutation or by titration of the drug through over-
production of the target.  MDR TB usually results
from accumulation of individual target genes10.  The
list of various gene loci conferring resistance in
M.tuberculosis are listed  in the accompanying table.
Important genotypoic drug susceptibility testing
methods are given as under:
Automated DNA sequencing
Among the molecular techniques available
DIAGNOSIS  OF  TUBERCULOSIS
Table: Various  gene  loci  conferring  drug  resistance  in  M.tuberculosis
Drug Gene Gene product/functional role Cellular target 
Rifampicin 
 
 
Isoniazid 
 
 
 
 
 
INH- 
Ethionamide 
 
 
 
Streptomycin 
 
 
 
 
Fluroquino- 
lone 
 
Pyrazinamide 
 
 
Ethambutol 
rpoB 
 
 
KatG 
 
 
OxyR-ahpC 
Kas A 
 
inhA 
 
 
 
 
rpsl 
 
 
rrs 
 
gyrA 
 
 
pncA 
 
 
embCAB 
B sub-unit of RNA 
polymerase/transcription 
 
Catalase-peroxidase/Activation 
of pro-drug 
Alkyl-hydro-reductase 
β-ketoacyl acyl carrier  
protein 
 
Enoyl-ACP reductase/ 
Synthase; 
Mycolic acid 
Biosynthesis 
 
Ribosomal protein S12/ 
Translation 
 
16s rRNA/translation 
 
DNA gyrase 
 
 
Amidase/Activation 
of pro-drug 
 
Arabinosyl transferase/ 
Arabinan; polymerization  
Nucleic acids 
 
 
Cell wall 
 
 
 
 
 
Cell wall 
 
 
 
 
Protein 
Synthesis 
 
 
 
Nucleic acids 
 
 
Unknown 
 
 
Cell wall 
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to detect M.tuberculosis drug resistance, DNA
sequencing of PCR amplified products are most
widely used and is becoming the gold standard for
this purpose.  It has been performed by both manual
and automated procedures, though the latter is most
commonly used.  The DNA sequencing is used for
characterization of the mutation responsible for drug
resistance.  This technique is being mainly used for
drugs like Rifampicin, Isoniazid, Streptomycin and
Ciprofloxacin11.
PCR SSCP
PCR SSCP is based on the property of single-
stranded DNA to fold into a tertiary structure whose
shape depends on its sequence.  Single strands of
DNA differing by only one or a few bases will fold
into different conformations with different mobilities
on a gel, producing what is called a single strand
conformation polymorphism (SSCP).  In
combination with PCR, SSCP has been applied for
the detection of resistance to Rifampicin, Isoniazid,
Streptomycin and Ciprofloxacin12.  The whole
process can be automated for use in large reference
laboratories.
PCR HDF
This assay is performed by mixing amplified
DNA from the test organisms and susceptible control
strains to obtain hybrid complementary DNA.  If a
resistant strain is present, the mutation will produce
a heteroduplex which has different electrophoretic
mobility compared with the homoduplex hybrid (no
mutation present).  The PCR-HDF is used to detect
all Rifampicin resistant strains having mutation within
the 305-bp region of the rpo B gene13.  This assay
can be used cost-effectively only in reference
laboratories with a large number of specimens where
the cost of the test per specimen can be reduced.
LiPA (Solid phase hybridization assay)
The line probe assay or LiPA is a commercial
test for the rapid detection of M.tuberculosis complex
and Rifampicin resistance.  The LiPA is based on the
hybridization of amplified DNA from the cultured
strains or clinical specimens to ten probes
encompassing the core region of the rpo B gene of
M.tuberculosis, which is immobilized on a
nitrocellulose strip.  The absence of hybridization of
the amplified DNA to any of the sensitive sequence-
specific probes indicates mutations that may encode
resistance; likewise, if hybridization to the mutation-
specific probes occurs, the mutation is present14.
Miscellaneous genotypic methods
These include new genotypic techniques for
the rapid detection of drug resistance in
M.tuberculosis.  Cleavage fragment length
polymorphism (CFLP)15, dideoxy fingerprinting
(ddf)16, hybridization protection assays17, a technique
based on reverse transcriptase-strand displacement
amplification of m-RNA18, RNA-RNA duplex base-
pair mismatch assay19 and DNA sequence analysis
using fluorogenic reporter molecules20 (i.e. molecular
beacons).  However, these techniques have not been
extensively studied and have not been further
validated with clinical isolates.  Although they share
a high specificity common to all sequencing
techniques, most of them rely on technically
demanding procedures and in some cases need
specialized and costly equipment precluding their use
at the clinical laboratory level, not to mention
mycobacteriology laboratories in developing
countries where TB is more prevalent.
DNA strain typing using RFLP
The pr inc ip le  beh ind  the  RFLP
technique is that if a single base difference
between otherwise two identical pieces of
double stranded DNA is lying within the
recognition site of restriction endonuclease, then
digestion of both the samples with that restriction
endonuclease will produce different products
which can be resolved by electrophoresis resulting
in different handling patterns called genomic or
DNA fingerprints.  Differences in banding patterns
are referred to as RFLPs, RFLP typing of
M.tuberculosis  isolates is useful for
epidemiological investigations in the spread of
particular strains especially multi drug resistant
strains and also to learn about relapse following
successful treatment, and to know whether it is
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due to endogenous reactivation or exogenous
reinfection21.
CONCLUSION
Many new possibilities have emerged for
the detection of drug resistance in M.tuberculosis
and for performing drug susceptibility tests.  These
novel methods rely on new information concerning
molecular mechanisms of drug resistance, or on new
approaches in detecting mycobacterial growth.  The
genotypic methods have the advantage of being rapid
and specific.  However, not all of the molecular
mechanisms of drug resistance are known; hence
the current molecular tools cannot detect all resistant
strains.  The phenotypic methods are more diverse;
some of them though simple in their procedure, still
require expensive equipment, not always available in
laboratories of TB endemic countries.  Some of them
are very useful, being low-tech and simple so that
they can be routinely used in developing countries,
while others need further evaluation and validation
to obtain acceptable levels of sensitivity, specificity
and reproducibility before they replace the current
drug susceptibility test procedures.
Today, although many new techniques
are available for the diagnosis of TB and also
for detection and identification of
M.tuberculosis, detection of AFB by direct
microscopy is the only feasible method
recommended for the tuberculosis control
programme of India in detecting infectious
pulmonary tuberculosis cases and for
monitoring the progress of patients during
treatment.  Wherever facilities are available,
isolation of mycobacteria by culture, and drug
sensitivity testing by conventional methods to
detect MDR TB cases stil l  remain the
recommended methods in disease endemic
countries .   Faster culture methods using
radiometric systems such as BACTEC or non-
radiometric systems like MGIT, etc. are being
used increasingly mainly because they reduce the
time needed for culture and drug sensitivity testing
to about 2-3 weeks.  Nucleic acid amplification
techniques are used mainly for cases where there
is a chance that the infection may be due to a
mycobacterium other than M.tuberculosis.  It is
also to be noted that most of the new techniques
described involve prohibitive expenditure in terms
of instrumentation, expertise and reagents, putting
them out of reach of many laboratories in
developing countries including India.
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